Synthesis and Bioactivity Evaluation of Novel Thiochroman-4-One Derivatives Incorporating Carboxamide and 1, 3, 4-Thiadiazole Thioether Moieties

Table 2

The EC₅₀ values of some of the target compounds against Xoo and Xac.

Compounds	EC50 (μg/mL)
	Xoo	Xac
5a	24 ± 2.25	30 ± 2.18
5b	32 ± 1.65	40 ± 2.49
5c	45 ± 2.05	51 ± 2.65
5f	26 ± 1.54	35 ± 2.65
5g	54 ± 1.94	61 ± 2.27
Bismerthiazol	84 ± 2.89	145 ± 2.65
Thiadiazole copper	109 ± 3.01	230 ± 2.46